Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease

One of 80 reports in the series: Background paper available on this site.
Thumbnail image of item number 1 in: 'Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease'.
Thumbnail image of item number 2 in: 'Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease'.
Thumbnail image of item number 3 in: 'Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease'.
Thumbnail image of item number 4 in: 'Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease'.
Showing 1-4 of 41 pages in this report.

PDF Version Also Available for Download.

Description

This background paper describes the development of alglucerase, illustrates the role that both the Federal Government and private sector can have in making new therapies available for orphan diseases, and lays out some of the tradeoffs that can exist between developing new medical technologies and controlling health care costs.

Physical Description

41 p. : ill. ; 28 cm.

Creation Information

United States. Congress. Office of Technology Assessment. October 1992.

Context

This report is part of the collection entitled: Office of Technology Assessment and was provided by the UNT Libraries Government Documents Department to the UNT Digital Library, a digital repository hosted by the UNT Libraries. It has been viewed 242 times. More information about this report can be viewed below.

Who

People and organizations associated with either the creation of this report or its content.

Author

Publisher

Provided By

UNT Libraries Government Documents Department

Serving as both a federal and a state depository library, the UNT Libraries Government Documents Department maintains millions of items in a variety of formats. The department is a member of the FDLP Content Partnerships Program and an Affiliated Archive of the National Archives.

About | Browse this Partner

Contact Us

Corrections Questions

What

Descriptive information to help identify this report. Follow the links below to find similar items on the Digital Library.

Titles

  • Main Title: Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease
  • Series Title: Background paper

Description

This background paper describes the development of alglucerase, illustrates the role that both the Federal Government and private sector can have in making new therapies available for orphan diseases, and lays out some of the tradeoffs that can exist between developing new medical technologies and controlling health care costs.

Physical Description

41 p. : ill. ; 28 cm.

Language

Item Type

Identifier

Unique identifying numbers for this report in the Digital Library or other systems.

Collections

This report is part of the following collection of related materials.

Office of Technology Assessment

The Office of Technology Assessment (OTA) operated from 1972 to 1995, providing Congressional members and committees with analyses of the scientific and technological issues that were increasingly relevant to public policy and legislative action. This collection includes quarterly and annual reports, as well as internal OTA documents such as orientation materials. Many other interesting OTA materials are available in the OTA Legacy Collection via the CyberCemetery.

About | Browse this Collection

What responsibilities do I have when using this report?

Digital Files

When

Dates and time periods associated with this report.

Creation Date

  • October 1992

Added to The UNT Digital Library

  • Aug. 20, 2011, 9:15 p.m.

Description Last Updated

  • April 1, 2016, 1:56 p.m.

Usage Statistics

When was this report last used?

Yesterday: 0
Past 30 days: 0
Total Uses: 242
More Statistics

Where

Geographical information about where this report originated or about its content.

Place Name

Publication Place

Map Information

  • map marker Place Name coordinates. (May be approximate.)
  • Repositioning map may be required for optimal printing.

Mapped Locations

Interact With This Report

Here are some suggestions for what to do next.

Start Reading

Thumbnail image of item number 1 in: 'Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease'.
Thumbnail image of item number 2 in: 'Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease'.
Thumbnail image of item number 3 in: 'Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease'.
Thumbnail image of item number 4 in: 'Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease'.

PDF Version Also Available for Download.

Citations, Rights, Re-Use

International Image Interoperability Framework

IIF Logo

We support the IIIF Presentation API

Links for Robots

Helpful links in machine-readable formats.

Archival Resource Key (ARK)

International Image Interoperability Framework (IIIF)

Metadata Formats

Images

URLs

Stats

United States. Congress. Office of Technology Assessment. Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease, report, October 1992; [Washington D.C.]. (https://digital.library.unt.edu/ark:/67531/metadc39697/: accessed April 25, 2024), University of North Texas Libraries, UNT Digital Library, https://digital.library.unt.edu; crediting UNT Libraries Government Documents Department.

Back to Top of Screen